Ticker
YMABCompany Name
Y-MABS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -17.8M | $ -0.39 | 1 | 45.32M |
3/31/2025 | $ -19.15M | $ -0.42 | 1 | 45.1M |
12/31/2024 | $ -15.71M | $ -0.35 | 1 | 44.33M |
9/30/2024 | $ -21.88M | $ -0.49 | 1 | 44.63M |
6/30/2024 | $ -12.55M | $ -0.29 | 1 | 44.02M |
3/31/2024 | $ -17.59M | $ -0.4 | 1 | 43.78M |
12/31/2023 | $ -27.23M | $ -0.62 | 1 | 43.65M |
9/30/2023 | $ -27.86M | $ -0.64 | 1 | 43.62M |
6/30/2023 | $ -45.75M | $ -1.05 | 1 | 43.66M |
3/31/2023 | $ -64.12M | $ -1.47 | 1 | 43.67M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / (Shares WA * Share Factor)
(=) OCFPS
OCFPS for Y-MABS THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -98.11M ] / (Shares WA [ 40.19M ] * Share Factor [ 1 ])
(=) OCFPS [ $ -2.44 ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 3.79K |
---|---|
min | $ -9.04 |
max | $ 11.43 |
average | $ 1.65 |
median | $ 0.89 |
std | $ 3.42 |